StonvexLoading…
StonvexStonvexStonvexCore line items from SGMO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.44M | $39.55M | $25.32M | $24.74M |
Operating Income | $-31.95M | $-121.24M | $-83.04M | $-47.48M |
Net Income | $-31.00M | $-122.93M | $-85.51M | $-50.58M |
EPS (Diluted) | $-0.08 | $-0.44 | $-0.33 | $-0.21 |
Total Assets | $59.97M | $59.74M | $88.64M | $97.56M |
Total Liabilities | $78.92M | $74.01M | $82.40M | $77.96M |
Cash & Equivalents | $27.59M | $20.95M | $29.62M | $38.34M |
Free Cash Flow OCF − CapEx | $-19.30M | $-97.31M | $-72.89M | $-44.33M |
Shares Outstanding | 389.62M | 350.69M | 260.80M | 238.71M |